Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,375 | 269 | 94.8% |
| Education | $239.67 | 4 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $860.57 | 55 | $0 (2024) |
| Novo Nordisk Inc | $843.47 | 54 | $0 (2024) |
| Lilly USA, LLC | $815.43 | 50 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $650.33 | 37 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $212.46 | 1 | $0 (2020) |
| Corcept Therapeutics | $146.70 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $143.58 | 9 | $0 (2024) |
| Amgen Inc. | $135.80 | 8 | $0 (2019) |
| PFIZER INC. | $121.55 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $117.35 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.34 | 33 | AstraZeneca Pharmaceuticals LP ($173.33) |
| 2023 | $526.82 | 31 | Lilly USA, LLC ($89.48) |
| 2022 | $481.47 | 31 | Lilly USA, LLC ($134.41) |
| 2021 | $536.71 | 34 | Lilly USA, LLC ($144.47) |
| 2020 | $829.16 | 38 | BOSTON SCIENTIFIC CORPORATION ($212.46) |
| 2019 | $431.97 | 27 | SANOFI-AVENTIS U.S. LLC ($100.94) |
| 2018 | $589.05 | 39 | AstraZeneca Pharmaceuticals LP ($156.42) |
| 2017 | $624.11 | 40 | Novo Nordisk Inc ($171.55) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: VACCINE | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Endocrinology | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA, SYNJARDY | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: DIABETES | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: VACCINES | ||||||
| 04/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Endocrinology | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Endocrinology | ||||||
| 03/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.86 | General |
| 03/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: VACCINES | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,212 | 3,111 | $395,060 | $161,954 |
| 2022 | 24 | 1,527 | 2,151 | $324,937 | $129,525 |
| 2021 | 29 | 1,792 | 3,837 | $399,486 | $188,980 |
| 2020 | 26 | 1,451 | 3,798 | $484,967 | $185,588 |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 521 | $132,855 | $37,157 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 200 | 200 | $48,000 | $27,098 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 549 | $104,310 | $24,647 | 23.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 1,260 | $32,100 | $23,069 | 71.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 72 | 73 | $23,725 | $20,583 | 86.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 96 | 96 | $8,160 | $6,905 | 84.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 123 | 123 | $4,920 | $3,998 | 81.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 28 | $9,100 | $3,927 | 43.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 21 | $7,875 | $3,582 | 45.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 49 | $6,615 | $3,216 | 48.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 76 | 77 | $3,080 | $2,503 | 81.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,935 | $1,985 | 40.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 15 | 16 | $2,240 | $1,184 | 52.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 16 | $1,920 | $1,075 | 56.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 29 | 29 | $2,465 | $635.10 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 32 | $2,760 | $392.00 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 428 | $109,140 | $35,706 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 250 | 580 | $110,200 | $29,746 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 176 | 176 | $42,240 | $24,609 | 58.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 79 | 80 | $6,785 | $5,480 | 80.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 115 | 115 | $7,475 | $4,827 | 64.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 27 | 28 | $9,100 | $4,455 | 49.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 114 | 116 | $4,640 | $3,690 | 79.5% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 82 | 82 | $4,920 | $3,476 | 70.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 56 | $7,560 | $3,346 | 44.3% |
About Dr. Jin Gu, MD
Dr. Jin Gu, MD is a Internal Medicine healthcare provider based in Towson, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154420727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jin Gu, MD has received a total of $4,615 in payments from pharmaceutical and medical device companies, with $595.34 received in 2024. These payments were reported across 273 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,375).
As a Medicare-enrolled provider, Gu has provided services to 5,982 Medicare beneficiaries, totaling 12,897 services with total Medicare billing of $666,047. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Towson, MD
- Active Since 09/21/2006
- Last Updated 12/21/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154420727
Products in Payments
- TRULICITY (Drug) $568.29
- FARXIGA (Drug) $531.99
- Ozempic (Drug) $445.14
- SOLIQUA 100/33 (Biological) $344.54
- TOUJEO (Drug) $245.76
- GENERAL ATHERECTOMY (Device) $212.46
- BYDUREON (Drug) $160.56
- Victoza (Drug) $157.65
- Korlym (Drug) $146.70
- EMGALITY (Drug) $133.20
- XARELTO (Drug) $117.35
- PREVNAR 20 (Biological) $94.83
- Prolia (Biological) $86.83
- MOUNJARO (Drug) $82.99
- BREZTRI (Drug) $76.11
- Rybelsus (Drug) $68.22
- ENTRESTO (Drug) $66.20
- SHINGRIX (Biological) $53.20
- Aimovig (Biological) $48.97
- UBRELVY (Drug) $48.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Towson
Vikas Kalra, Md, MD
Internal Medicine — Payments: $20,342
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,308
Dr. David Edwards, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $14,404
Albert Deloskey, M.d, M.D
Internal Medicine — Payments: $14,028
Latrica Cook, M.d, M.D
Internal Medicine — Payments: $8,868
Madhat Arnouk, M.d, M.D
Internal Medicine — Payments: $8,212